Nurix: New Preclinical Data Supporting NX-2127 and DeTIL-0255 Clinical Programs at AACR

 Studies provide insight into bifunctional molecular mechanism and first in vivo demonstration of immunomodulatory imide drug (IMiD) activity of NX-2127, resulting in robust tumor cell killing

Animal models of adoptive cell therapy support the use of NX-0255 in the production of an investigational drug-enhanced TIL therapy, DeTIL-0255

https://finance.yahoo.com/news/nurix-therapeutics-presents-preclinical-data-170200069.html